Company profile for Convergent Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Convergent Therapeutics, Inc. is a biotechnology company focused on developing next-generation targeted combination therapies to treat cancer.Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakt...
Convergent Therapeutics, Inc. is a biotechnology company focused on developing next-generation targeted combination therapies to treat cancer.Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Cambridge, MA
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/convergent-therapeutics-announces-two-clinical-trial-updates-on-conv01--at-the-american-society-of-clinical-oncology-asco-genitourinary-cancers-symposium-2025-302372722.html

PR NEWSWIRE
10 Feb 2025

https://www.prnewswire.com/news-releases/convergent-therapeutics-appoints-barbara-duncan-to-board-of-directors-302328417.html

PR NEWSWIRE
11 Dec 2024

https://www.prnewswire.com/news-releases/convergent-therapeutics-announces-first-shipments-of-actinium-225-from-cardinal-health-to-support-the-converge-01-phase-2-clinical-trial-302307505.html

PR NEWSWIRE
18 Nov 2024

https://www.prnewswire.com/news-releases/convergent-therapeutics-announces-first-patient-treated-in-phase-ii-clinical-trial-with-lead-therapeutic-candidate-and-corporate-updates-302256398.html

PR NEWSWIRE
24 Sep 2024

https://www.businesswire.com/news/home/20240813680881/en

BUSINESSWIRE
13 Aug 2024

https://www.prnewswire.com/news-releases/convergent-therapeutics-appoints-scott-myers-as-chairman-of-its-board-of-directors-302077694.html

PR NEWSWIRE
04 Mar 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty